Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin: Results From a Randomized Double Blinded Clinical Trial

NCT04829903 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT04829903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04829903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin: Results From a Randomized Double Blinded Clinical Trial
Lead sponsor
Corporacion Parc Tauli
Phase
Not applicable
Overall status
Completed
Start date
January 2, 2020
Completion date
November 20, 2021
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adolescent obesity, obesity, type 2 diabetes treated with insulin